Jaiwant Rangi, MD, FACEEndocrinologist | Founder, Lower The Dose® | Speaker

Decoding Diabetes: Moving Beyond Labels to Personalized Medicine

11 Sept 2026 · 1 min

Watch on YouTube

0:46

Dr. Jaiwant Rangi argues that diabetes is far more varied than type 1 or type 2, with forms like LADA, MODY, and gestational diabetes requiring different approaches. Medicine has relied on a single label and one number, HbA1c, when patients need personalized treatment based on their actual biology.

Chapters

You have type 1 diabetes, type 2 diabetes, then there's something called LADA, or latent autoimmune diabetes of adults. Then there's something called MODY, M-O-D-Y, which is a genetic condition. Then you have gestational diabetes, which happens during pregnancy, and the high-risk profile some lean and ethnically predisposed adults carry. Some diabetes don't have a name, but they may present in a certain way, and their response is very different for the treatment plan that we choose for them. So we need to recognize that there's different patterns and different types of diabetes. that happen. We have spent decades treating one number and one label. We try to treat type 2 diabetes as if it tells the whole story.